Use of copaiba oil-based emulsion in the teeth restoration process

Clinical Trial of Copaifera multijulga Hayne oil-based Emulsion as a biomodifier of dentin adhesion

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

REBEC

Registry ID

RBR-3g6q92

Enrollment

Unknown

Registered

2020-03-18

Start date

2020-04-06

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Carie

Interventions

The Clinical Trial will consist of a case group with the Copaiba oil-based emulsion (Copaifera multijuga Hayne) and a control group (2% chlorhexidine digluconate emulsion). Case group: 52 participants

Other

E06.323.428

Eligibility

Age

7 Years to 11 Years

Inclusion criteria

Inclusion criteria: The participant must present deciduous molar teeth with up to 1/3 of root resorption affected by a shallow or medium occlusive-proximal caries lesion with surrounding enamel throughout; do not present dental malformation and spontaneous pain in the teeth. Do not have systemic disease, such as diabetes, hypertension and heart disease.

Exclusion criteria

Exclusion criteria: Patients will be excluded if there is a fistula or edema in the intra or extra-oral region, radiolucency in the furcation region of the tooth, or if the successor tooth of the deciduous tooth is missing.

Design outcomes

Primary

Measure	Time frame
It is expected that when analyzing the quality of the hybrid layer on the dentin surface using the Copaíba oil-based emulsion, it will be shown to be equal or better when compared to chlorhexidine digluconate through scanning electron microscopy and histomorphometry.	—

Secondary

Measure	Time frame
Secondary outcomes are not expected.	—

Countries

Brazil

Contacts

Public ContactFulgência;Geisy Bandeira;Lima

Universidade Federal do Amazonas;Universidade Federal do Amazonas

fulgencia@ufam.edu.br;geisylima@hotmail.com+55 092 98114-2527 ;+55 092 993320279

Outcome results

None listed

Source: REBEC (via WHO ICTRP)